Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Feb 03, 2017

4 Investment Tips for 2017

With the New Year comes new investment themes. The sectors/countries/industries that outperformed in 2016 may not necessarily outperform in 2017. In 2016, the top three performing sectors in the US were Energy (+27.4%), Utilities (+23.5%), and Financials (+22.8%). From a country standpoint, the best performers were Brazil (+38.9%), Canada (+17.5%), and the UK (+14.4%). The US wasn't far behind, however, posting a solid 12% return for the year (S&P 500).

It is rare in the equities markets for the same category or sector to outperform two or more years in a row. Leadership often changes hands, and in some cases the best performing sector or country in one year can be the worst performer the next. That's why it makes sense to diversify across many sectors, industries, and countries when you invest. That way, you can give yourself a better chance at capturing the best performing area of the market and not get too weighed down by the lagging parts. Diversification helps to smooth out returns over time.

Now, onto the investment tips. The first tip is for investors to have as much equity exposure as they're comfortable with (from a risk tolerance perspective) and in accordance with your investment objectives. If you're young, have appetite for risk, and are looking for long-term growth, I'd recommend taking a full allocation to stocks.

In the equity portion of investor portfolios, I think there are four areas that could stand to outperform:

Investment Tip #1: Overweight to US Financials

There are two tailwinds brewing that could give US Financials (specifically, large banks) a boost. The first is the Trump Administration's promise to roll back regulations on the industry, namely those associated with Dodd-Frank. Looser regulations could inspire banks to take more risk, which could ultimately lead to better earnings. The second tailwind has to do with the yield curve. Longer term bond yields rose in the months following Trump's victory, perhaps as the market started to price-in the possibility of higher inflation in the coming year. As bond yields rose, the yield curve got steeper, and a steeper yield curve is good for banks. The steeper the yield curve, the higher the net interest margins for banks.

 

 

Investment Tip #2: Exposure to Europe

For the first time since 2008, the Euro-area grew at a faster pace than the US. Brexit was a hit to the European Union, but the effects aren't likely to be felt until 2019 or even later. The other factor to watch are elections in Germany, the Netherlands, France, and Italy - all of which will inform us whether the populist movement really has legs. Populist victories would mean a threat to the economic order of the European Union, which could rattle markets. My guess: the anti-euro parties won't gain big victories and the uncertainty around the viability of the European Union will fade. Markets should rally on that news and the area should continue to expand. 

Investment Tip #3: Overweight to Industrials

The Trump Administration has promised to spend significant money to rebuild roads, airports, and potentially a wall bordering Mexico. If his plans go through or some version of them passes, that could mean some fresh activity for Industrials companies. 

Investment Tip #4: Overweight to US Midcap Companies

Trump's "America First" policies may end up resulting in some trade barriers and tariffs against foreign goods entering the US. Those policies, and a stronger dollar, could lead domestic companies to outperform multinationals. You tend to find the pure domestic companies in the small- to mid-cap space, and I'd favor Midcap over small-cap. Small caps tend to outperform early in economic cycles, and we're already entering the eighth year of this one. 

For more investment ideas, check out the Artificial Intelligence tool on tickeron.com. It can generate investment ideas that might surprise you - and make you some money.


Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


Interact to see
Advertisement
Defense budgets worldwide are surging — global military spending topped $2.2 trillion in 2023, a record high — while semiconductor demand is projected to reach a $1 trillion industry by 2030. At the intersection of these two mega-trends sits one of Tickeron's most strategically focused AI Trading Robots: the XAR, ITA, SOXL – AI Trading Agent (3 Tickers), 15min.
HIMS shares surged approximately +43.85% in premarket trading on Monday, March 9, 2026, rising from a prior close of $15.74 to around $22.80. Primary catalyst: Novo Nordisk officially ended its patent infringement lawsuit against Hims & Hers and announced a landmark partnership to distribute branded Wegovy through the Hims platform at $599/month.
XENE shares surged approximately +45.93% in premarket trading on March 9, 2026, one of the largest single-session moves in the company's history. The primary catalyst: Xenon announced positive topline Phase 3 X-TOLE2 results for its lead drug candidate azetukalner in focal onset seizures (FOS), meeting the primary endpoint with overwhelming statistical significance.
Shares of OLMA dropped approximately 41% in Monday's session, one of the steepest single-day declines in the company's history. The primary catalyst was Roche's Phase 3 persevERA trial failure — a late-stage study of giredestrant, a closely competing selective estrogen receptor degrader (SERD), which missed its primary endpoint of statistically significant improvement in progression-free survival.
RLMD shares surged approximately +40% at the open on March 9, 2026, rising from a prior close of $4.45 to approximately $6.23, driven by a major clinical trial readout. The primary catalyst was the announcement of 12-month interim data from the Phase 2 trial of NDV-01, Relmada's lead oncology candidate, in patients with high-risk non-muscle invasive bladder cancer (NMIBC) — results that significantly exceeded historical benchmarks.
CRCL surged +8.66% on Monday, March 9, 2026, rising from a prior close of $101.94 to trade at $110.77 intraday. The primary catalyst is a landmark stablecoin milestone: Circle's USDC overtook Tether as the dominant stablecoin by transfer volume, accounting for approximately 70% of all stablecoin transfer activity as total stablecoin transfers hit $1.8 trillion in February.
Carnival Corporation (CCL) shares fell approximately -7.60% in Monday's session, dropping from a Friday close of $25.79 to around $23.83. The primary catalyst is a broad market sell-off driven by intensifying recession fears, with the S&P 500 and consumer discretionary names bearing the brunt of the pressure.
Shares of Bloom Energy (BE) are surging approximately +10.30% in Monday's session, rebounding sharply from a steep -15.50% selloff on Friday, March 6, 2026. Friday's decline was triggered by an Oracle-OpenAI data center project update that spooked energy infrastructure investors; Monday's move reflects aggressive dip-buying and a sentiment reset.
IGV has rallied about 8–9% in the last 6 trading days, while SOXX has dropped about 8%, giving software a +16.6 percentage‑point edge—the largest 6‑day software‑over‑semi outperformance ever.[barchart]​ This comes right after software lagged semis by almost −15 percentage points into late January, the widest gap since 2008, and as hedge‑fund short exposure to U.S. software and services hit a record ~3.8% of market cap.
Crude’s explosive war‑driven spike faded on March 9 because the market suddenly started to price less extreme, shorter‑lived supply risk and more policy intervention, not a multi‑month shortage. WTI, which had briefly traded above 115–120 dollars on Iran‑war headlines and Strait of Hormuz fears, slid back toward the high‑80s as traders digested G7 reserve‑release talk, Trump’s comments about a “brief” war, and the reality that prices had run far ahead of fundamentals.
Shares of ARQ plunged approximately 27.50% in premarket trading on March 10, 2026, from a prior close of $3.20 to roughly $2.32. The primary catalyst was a deeply disappointing Q4 2025 earnings report, which revealed a net loss of $50.0 million for the quarter versus a net loss of $1.3 million in Q4 2024.
RAIL shares fell approximately 15% in premarket trading on March 10, 2026, following a steep after-hours reaction to disappointing Q4 2025 earnings results released after the close on March 9. The primary catalyst was a significant revenue miss: Q4 revenue came in at $125.6 million, well below consensus estimates near $144–$160 million, representing an 8.8% year-over-year decline.
ZVRA shares surged approximately +17.86% on March 10, 2026, driven by a blockbuster Q4 and full-year 2025 earnings report released before the market open. Primary catalyst: Q4 2025 EPS of $0.19 crushed the consensus estimate of $0.05 — a 280% beat — while revenue of $34.1 million exceeded forecasts by 21.57%.
LITE surged +14.73% on Monday, March 9, 2026, closing at $640.69 versus a prior close of $558.44 on March 6. The primary catalyst was the landmark $2 billion strategic investment by NVIDIA announced March 2, with the market continuing to price in its full implications following a brief post-announcement pullback.
Shares of BNTX fell approximately 22% on Tuesday, March 10, 2026, following a dual shock of disappointing full-year guidance and a surprise leadership upheaval. The primary catalyst was BioNTech's Q4 2025 earnings report, which included a 2026 revenue outlook of €2.0–€2.3 billion — well below analyst consensus and signaling continued pressure from declining COVID-19 vaccine demand.
CNC shares fell approximately 10% during Tuesday's session, extending a prolonged selloff in the managed care sector. The primary catalyst is intensifying investor concern over federal Medicaid and ACA funding cuts tied to the "One Big Beautiful Bill Act" (OBBBA), which threatens to shrink the government-sponsored insurance pools that Centene depends on for the majority of its revenue.
Technology recently peaked near 35% of the S&P 500 and has slipped over the last year, while Energy plus Materials remain near historically low combined weight at roughly 6%, which suggests the gap is still unusually wide.
Average daily equity purchases by retail investors on S&P 500 down days in 2026 are at the highest level on record, running about 100% above the peak intensity seen during the 2021 meme‑stock boom.
Over the past two weeks, PLTR has climbed from roughly the high‑130s to the mid‑150s, a gain of about 12–14%, with a series of strong up days between March 2 and March 6.
AVAV shares dropped approximately 10% in premarket trading on March 11, 2026, following a disappointing Q3 fiscal 2026 earnings report released after the prior session's close. Q3 revenue of $408.0 million came in far below analyst consensus of approximately $475–$488 million, representing a massive top-line miss.